VCBeat Health
Contact Us
Home
China Healthcare Select
Insights
MNC China Lens
Vertical Industries
Services
Partnership Development
Market Entry Advisory
Ecosystem Engagement Advisory
About VCBeat
Why VCBeat
Log In
Home
Phase 2 Primary Endpoint Missed, Biogen Still Pushes Diranersen to Phase 3
Phase 2 Primary Endpoint Missed, Biogen Still Pushes Diranersen to Phase 3
May 23, 2026 12:10 CST Updated 13:17
Share:
Biogen
New Drug Developer
